Healthcare -
Biotechnology - NASDAQ - US
$ 0.2962
-0.135 %
$ 21.5 M
Market Cap
-0.4
P/E
INAB - COST OF REVENUE
Cost of Revenue INAB - IN8bio, Inc.
2.5 M
LAST VALUE
215.66%
2 YEAR CAGR
91.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR